Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Late-cycle stock sectors in focus amid U.S. economic uncertainty

EditorRachael Rajan
Published 19/09/2023, 05:38 am
Updated 19/09/2023, 05:38 am
© Reuters.

As the U.S. economy's position within the business cycle remains uncertain, investors are being encouraged to focus on late-cycle stock sectors. The recommendation comes from Mike Wilson, Morgan Stanley (NYSE:MS)'s chief U.S. equity strategist, who advised maintaining a barbell portfolio until more definitive data emerges.

Wilson's proposed barbell portfolio would balance defensive growth sectors like healthcare and consumer staples with late-cycle cyclicals such as industrials and energy. Despite underperformance this year, Wilson emphasized that it is premature to shift investments towards small to mid caps, citing the Russell 2000 RUT's mere 4% increase in 2023.

The energy sector has been attracting investor attention due to rising crude prices, recently nearing $92 per barrel. Wilson views this sector as a typical late-cycle outperformer, often buoyed by commodity strength. He pointed to strong oil demand, significant production cuts, and stable crude prices as factors supporting the sector's performance.

The energy sector's appeal is further boosted by its recovery from an underperformance period that spanned from November last year until July this year. Currently, the sector presents attractive valuations and accelerated earnings revisions, while generating substantial free cash flow and having the ability to pay off debt if needed. This recovery occurs as hedge fund exposure to the energy sector remains historically low.

Wilson also spotlighted a range of defensive growth stocks that have outperformed both yearly and more recently. These stocks, all rated overweight by Morgan Stanley, include Accenture (NYSE:ACN) ACN, Apple (NASDAQ:AAPL), AutoZone (NYSE:AZO) AZO, Biomarin Pharmaceutical BMRN, and Boston Scientific (NYSE:BSX) BSX.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Most U.S. investors expect that large-cap winners will continue to lead during the fourth quarter if the broader market remains stable. Wilson observed similar concerns among European and U.S. clients regarding the current economic cycle stage and performance disparities.

Investors are pondering whether the rest of the year will see continued dominance by mega cap growth or a shift towards underperforming areas such as value and small/mid cap stocks. However, Wilson maintains that it may still be too early for such a transition.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.